Clarius Group LLC’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.1M | Sell |
10,267
-1,226
| -11% | -$132K | 0.06% | 135 |
|
2025
Q1 | $1.16M | Buy |
11,493
+2,968
| +35% | +$299K | 0.07% | 129 |
|
2024
Q4 | $761K | Buy |
8,525
+567
| +7% | +$50.6K | 0.05% | 149 |
|
2024
Q3 | $664K | Sell |
7,958
-112
| -1% | -$9.35K | 0.05% | 173 |
|
2024
Q2 | $621K | Sell |
8,070
-271
| -3% | -$20.9K | 0.04% | 186 |
|
2024
Q1 | $571K | Sell |
8,341
-1,184
| -12% | -$81.1K | 0.04% | 201 |
|
2023
Q4 | $551K | Sell |
9,525
-423
| -4% | -$24.5K | 0.05% | 219 |
|
2023
Q3 | $525K | Sell |
9,948
-2,149
| -18% | -$113K | 0.05% | 208 |
|
2023
Q2 | $654K | Buy |
12,097
+60
| +0.5% | +$3.25K | 0.05% | 207 |
|
2023
Q1 | $602K | Buy |
12,037
+52
| +0.4% | +$2.6K | 0.05% | 215 |
|
2022
Q4 | $555K | Buy |
11,985
+655
| +6% | +$30.3K | 0.05% | 229 |
|
2022
Q3 | $439K | Sell |
11,330
-141
| -1% | -$5.46K | 0.04% | 244 |
|
2022
Q2 | $428K | Buy |
11,471
+1,229
| +12% | +$45.9K | 0.04% | 246 |
|
2022
Q1 | $435K | Hold |
10,242
| – | – | 0.03% | 269 |
|
2021
Q4 | $435K | Buy |
10,242
+169
| +2% | +$7.18K | 0.03% | 269 |
|
2021
Q3 | $437K | Buy |
10,073
+769
| +8% | +$33.4K | 0.04% | 244 |
|
2021
Q2 | $398K | Buy |
9,304
+335
| +4% | +$14.3K | 0.04% | 257 |
|
2021
Q1 | $347K | Buy |
8,969
+260
| +3% | +$10.1K | 0.03% | 262 |
|
2020
Q4 | $313K | Sell |
8,709
-692
| -7% | -$24.9K | 0.03% | 255 |
|
2020
Q3 | $359K | Buy |
9,401
+50
| +0.5% | +$1.91K | 0.05% | 189 |
|
2020
Q2 | $328K | Buy |
9,351
+356
| +4% | +$12.5K | 0.05% | 199 |
|
2020
Q1 | $294K | Buy |
8,995
+951
| +12% | +$31.1K | 0.06% | 182 |
|
2019
Q4 | $342K | Sell |
8,044
-1,136
| -12% | -$48.3K | 0.05% | 180 |
|
2019
Q3 | $374K | Buy |
9,180
+2,357
| +35% | +$96K | 0.07% | 156 |
|
2019
Q2 | $293K | Sell |
6,823
-1,046
| -13% | -$44.9K | 0.06% | 175 |
|
2019
Q1 | $302K | Buy |
+7,869
| New | +$302K | 0.07% | 140 |
|